应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01358 普华和顺
已收盘 09-14 16:08:02
0.930
-0.025
-2.62%
最高
0.945
最低
0.920
成交量
36.90万
今开
0.940
昨收
0.955
日振幅
2.62%
总市值
13.33亿
流通市值
13.33亿
总股本
14.33亿
成交额
34.45万
换手率
0.03%
流通股本
14.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
普华和顺9月11日回购10.60万股,耗资约10.31万港元
公告速递 · 09-11 19:12
普华和顺9月11日回购10.60万股,耗资约10.31万港元
普华和顺:9月10日回购70万股股份,总涉资约68.12万港元
公告速递 · 09-10
普华和顺:9月10日回购70万股股份,总涉资约68.12万港元
普华和顺(01358)9月10日耗资约68.12万港元回购70万股
智通财经 · 09-10
普华和顺(01358)9月10日耗资约68.12万港元回购70万股
普华和顺回购40.2万股股份,耗资约39.03万港元
公告速递 · 09-09
普华和顺回购40.2万股股份,耗资约39.03万港元
普华和顺(01358)9月8日斥资4.85万港元回购5万股
智通财经 · 09-08
普华和顺(01358)9月8日斥资4.85万港元回购5万股
普华和顺回购5万股股份,总额约4.85万港元
公告速递 · 09-08
普华和顺回购5万股股份,总额约4.85万港元
普华和顺回购7.8万股股份,总额约7.47万港元
公告速递 · 09-07
普华和顺回购7.8万股股份,总额约7.47万港元
普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股
智通财经 · 09-07
普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股
普华和顺再度回购10万股股份,涉资约9.50万港元
公告速递 · 09-04
普华和顺再度回购10万股股份,涉资约9.50万港元
普华和顺(01358)9月4日斥资9.5万港元回购10万股
智通财经 · 09-04
普华和顺(01358)9月4日斥资9.5万港元回购10万股
普华和顺回购19.6万股股份,总额约18.24万港元
公告速递 · 09-03
普华和顺回购19.6万股股份,总额约18.24万港元
普华和顺更新8月股份变动月报表,股本维持稳定
公告速递 · 09-03
普华和顺更新8月股份变动月报表,股本维持稳定
普华和顺回购47.3万股股份,涉资约43.14万港元
公告速递 · 09-02
普华和顺回购47.3万股股份,涉资约43.14万港元
普华和顺(01358)9月2日斥资43.14万港元回购47.3万股
智通财经 · 09-02
普华和顺(01358)9月2日斥资43.14万港元回购47.3万股
普华和顺(01358)发布中期业绩,股东应占溢利1469.2万元 同比减少77.74%
智通财经 · 08-29
普华和顺(01358)发布中期业绩,股东应占溢利1469.2万元 同比减少77.74%
普华和顺2026年中期业绩:营收3.94亿元,经调整净利润68.6百万元
公告速递 · 08-28
普华和顺2026年中期业绩:营收3.94亿元,经调整净利润68.6百万元
普华和顺(01358):四川睿健医疗中期归母净利润7890.5万元 同比增长8.2%
智通财经 · 08-21
普华和顺(01358):四川睿健医疗中期归母净利润7890.5万元 同比增长8.2%
普华和顺(01358)子公司四川睿健医疗披露2026年中期业绩:净利润7,673.51万元,同比增长9.15%
公告速递 · 08-21
普华和顺(01358)子公司四川睿健医疗披露2026年中期业绩:净利润7,673.51万元,同比增长9.15%
普华和顺(01358)将于2026年8月28日召开董事会审议中期业绩
公告速递 · 08-18
普华和顺(01358)将于2026年8月28日召开董事会审议中期业绩
普华和顺(01358.HK)发盈警,预期中期股东应占溢利1300万元至2000万元 同比减少80%至70%
智通财经 · 08-10
普华和顺(01358.HK)发盈警,预期中期股东应占溢利1300万元至2000万元 同比减少80%至70%
加载更多
公司概况
公司名称:
普华和顺
所属市场:
SEHK
上市日期:
--
主营业务:
普华和顺集团公司是一家主要从事医疗器械的研发(R&D)及销售业务的投资控股公司。该公司通过三个分部开展业务。输液器业务分部主要从事输液器、静脉留置针产品、胰岛素针等的研发、制造及销售。血液净化业务分部主要从事血液透析及血液净化医疗器械的研发、制造及销售。再生医用生物材料业务分部主要从事动物源性组织再生医用生物材料及人体组织修复替代产品的研发及制造。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01358","market":"HK","secType":"STK","nameCN":"普华和顺","latestPrice":0.93,"timestamp":1789373282219,"preClose":0.955,"halted":0,"volume":369000,"delay":0,"changeRate":-0.026178010471204098,"floatShares":1433000000,"shares":1433000000,"eps":0.0625,"marketStatus":"已收盘","change":-0.025,"latestTime":"09-14 16:08:02","open":0.94,"high":0.945,"low":0.92,"amount":344485,"amplitude":0.026178,"askPrice":0.945,"askSize":23000,"bidPrice":0.93,"bidSize":9000,"shortable":0,"etf":0,"ttmEps":0.034209477,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"listingDate":1383840000000,"exchange":"SEHK","adjPreClose":0.955,"dividendRate":0.068817,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":0.706355,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01358","defaultTab":"news","newsList":[{"id":"1182700215","title":"普华和顺9月11日回购10.60万股,耗资约10.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182700215","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182700215?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:12","pubTimestamp":1789125123,"startTime":"0","endTime":"0","summary":"普华和顺集团公司2026年9月11日发布翌日披露报表,公告当日于香港联交所场内回购普通股10.60万股,占公司已发行股份总数的0.0074%。回购价格介乎每股0.97港元至0.975港元,合计支出约10.31万港元。回购完成后,公司已发行股份仍为1,433,241,098股,库藏股数为0。根据公告,此次回购基于公司于2026年6月26日通过的购回授权,授权可回购股份总数为144,285,509股。至今累计回购股份4,520,000股,占授权决议通过当日已发行股本约0.3133%。本公告由公司董事张月娥签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺9月11日回购10.60万股,耗资约10.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147931055","title":"普华和顺:9月10日回购70万股股份,总涉资约68.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147931055","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147931055?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:40","pubTimestamp":1789040458,"startTime":"0","endTime":"0","summary":"普华和顺(01358)于2026年9月10日发布翌日报表,披露当日于香港联交所场内回购普通股70万股,占当日已发行股本约0.0488%。每股回购价介乎每股0.965港元至0.98港元,合计涉资约68.12万港元(约681,245.00港元)。该批股份暂未注销,公司已发行股本仍为1,433,241,098股,库藏股数为0股。\n此前,公司于2026年6月26日通过购回授权,授权总数为144,285,509股,截至目前已经于交易所累计回购4,414,000股,占授权通过时已发行股本的约0.3059%。公司确认上述回购事宜已遵守香港联交所证券上市规则及其他相关法例的规定。\n公告由公司董事张月娥签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺:9月10日回购70万股股份,总涉资约68.12万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666598562","title":"普华和顺(01358)9月10日耗资约68.12万港元回购70万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598562","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666598562?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:40","pubTimestamp":1789040435,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)公布,2026年9月10日耗资约68.12万港元回购70万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105121340","title":"普华和顺回购40.2万股股份,耗资约39.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105121340","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105121340?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:06","pubTimestamp":1788951970,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年9月9日发布翌日披露报表,宣布于当日通过香港联交所场内回购普通股402,000股,占此前已发行股份的约0.028%。每股回购价格介于港币0.97至0.98,合计动用资金390,320港元。公告显示,该等股份目前尚未注销,公司已发行股本暂保持在1,433,241,098股,库藏股为0股。公司此前于2026年6月26日获得股东大会批准回购授权,授权可回购股份总数为144,285,509股,截至本次回购,累计回购股份总数已达3,714,000股,占授权时已发行股本约0.2574%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购40.2万股股份,耗资约39.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322094","title":"普华和顺(01358)9月8日斥资4.85万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322094","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665322094?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:18","pubTimestamp":1788866299,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月8日斥资4.85万港元回购5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144293976","title":"普华和顺回购5万股股份,总额约4.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144293976","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144293976?lang=zh_cn&edition=full","pubTime":"2026-09-08 19:15","pubTimestamp":1788866150,"startTime":"0","endTime":"0","summary":"2026年9月8日,普华和顺公告披露,2026年9月8日于香港联交所场内回购普通股5万股,占公司已发行股本约0.0035%。此次回购每股价格为0.97港元,合计支付约4.85万港元。公告显示,上述回购股份暂未注销,回购完成后公司已发行股本仍为14.33亿股,库藏股数为0股。公司于2026年6月26日通过购回授权,可回购总数为1.44亿股。公司确认,此次回购已获董事会正式批准,并遵守香港联交所证券上市规则及相关法律法规。公告由董事张月娥签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购5万股股份,总额约4.85万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164409324","title":"普华和顺回购7.8万股股份,总额约7.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164409324","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164409324?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:46","pubTimestamp":1788778010,"startTime":"0","endTime":"0","summary":"普华和顺(01358)于2026年9月7日发布公告称,公司当日在香港联交所场内回购股份78,000股,占公司已发行股本约0.0054%,每股回购价格介乎0.955港元至0.97港元,合计付出约7.47万港元。\n公告显示,本次回购完成后,公司已发行股本维持在1,433,241,098股,当前库藏股数量为0。普华和顺于2026年6月26日获得购回授权,最多可购回144,285,509股,截至本次回购前公司已在本交易所或其他证券交易所累计回购股份3,262,000股,占该购回授权通过当日已发行股份数目的约0.2261%。公司确认已遵守香港联交所上市规则及相关法律法规;公告由董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购7.8万股股份,总额约7.47万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665316505","title":"普华和顺(01358.HK)9月7日斥资约7.47万港元回购7.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665316505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665316505?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:41","pubTimestamp":1788777710,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121166437","title":"普华和顺再度回购10万股股份,涉资约9.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121166437","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121166437?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:32","pubTimestamp":1788521571,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月4日发布公告,披露公司继续实施股份回购并更新已发行股本变动情况。公告显示,普华和顺于2026年9月4日在香港联交所场内回购普通股100,000股,约占当日公司已发行股本的0.007%。本次回购价格为每股0.95港元,耗资合共95,000港元,折合约9.50万港元。依据公告,普华和顺可根据该授权最多购回144,285,509股,至今已在交易所累计购回3,184,000股,占授权通过当日公司已发行股本约0.2207%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺再度回购10万股股份,涉资约9.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339301","title":"普华和顺(01358)9月4日斥资9.5万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339301","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664339301?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:19","pubTimestamp":1788520788,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月4日该公司斥资9.5万港元回购10万股,回购价格为每股0.95港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190639104","title":"普华和顺回购19.6万股股份,总额约18.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190639104","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190639104?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:22","pubTimestamp":1788434528,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月3日发布翌日披露报表,公告进行股份购回。公司于当日于香港联交所场内回购普通股合计196,000股,约占该公司现有已发行股本的0.0137%,每股回购价位介乎每股0.93港元至0.935港元,合计涉资182,380港元。根据公告,普华和顺已发行股份总数于此次回购后仍为1,433,241,098股,库藏股数量为零。下一次新股发行或再出售、转让库藏股的暂止期将持续至2026年10月3日。公司声明已遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购19.6万股股份,总额约18.24万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126668335","title":"普华和顺更新8月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1126668335","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126668335?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:51","pubTimestamp":1788425472,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月3日披露的截至2026年8月31日证券变动月报显示,公司本月未发生新增股份发行及已发行股份的实际变动,股本保持稳定。据公告,截至本报告期末,普华和顺的法定/注册股本维持在5,000,000,000股普通股,面值为每股0.0001美元,总额为500,000美元。公司方面表示,所有本月涉及的交易均已获得董事会正式授权,并遵从相关法律与监管规定。公告由公司董事张月娥签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199217305","title":"普华和顺回购47.3万股股份,涉资约43.14万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199217305","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199217305?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:45","pubTimestamp":1788349501,"startTime":"0","endTime":"0","summary":"普华和顺于2026年9月2日发布翌日报表公告,披露于当日在香港联交所场内回购股份47.3万股,占变动前已发行股本约0.033%,回购价格区间每股0.90港元至0.92港元,合计耗资约43.14万港元。公告显示,本次回购股份拟注销,变动后公司已发行股本仍为14.33亿股,且公司并无任何库藏股份。公司表示,其于2026年6月26日获得股东大会批准的购回授权可回购总数为1.44亿股。公司同时确认,已遵守香港联合交易所有限公司的证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺回购47.3万股股份,涉资约43.14万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819844","title":"普华和顺(01358)9月2日斥资43.14万港元回购47.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819844","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664819844?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:40","pubTimestamp":1788349244,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年9月2日斥资43.14万港元回购47.3万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097940","title":"普华和顺(01358)发布中期业绩,股东应占溢利1469.2万元 同比减少77.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097940","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663097940?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:27","pubTimestamp":1787934476,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布截至2026年6月30日止6个月的中期业绩,该集团取得收入人民币3.94亿元(单位下同),同比减少4.9%;本公司拥有人应占溢利1469.2万元,同比减少77.74%;每股盈利1.01分;中期股息每股1.1港仙。公告称,收入下降主要由于输液器业务销售额减少,部分被血液净化业务及再生医用生物材料业务销售额增长所抵销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186440607","title":"普华和顺2026年中期业绩:营收3.94亿元,经调整净利润68.6百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186440607","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186440607?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:37","pubTimestamp":1787927827,"startTime":"0","endTime":"0","summary":"根据最新公告,普华和顺截至2026年6月30日止六个月实现营收3.94亿元,同比下降4.9%。同期,经调整期内净溢利为68.6百万元,同比下滑42.4%;经调整本公司拥有人应占净溢利31.3百万元,较上年同期下降62.5%。报告期内,毛利率由51.3%下降至48.2%,主要受集中带量采购实施范围扩大、相关产品出厂价下降等影响。经营溢利为36.2百万元,同比减少54.9%。输液器业务方面,报告期内收入约为0.80亿元,同比下降29.1%,占总营收比重约20.4%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"普华和顺2026年中期业绩:营收3.94亿元,经调整净利润68.6百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661623142","title":"普华和顺(01358):四川睿健医疗中期归母净利润7890.5万元 同比增长8.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661623142","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661623142?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:44","pubTimestamp":1787309064,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布附属四川睿健医疗2026年中期业绩,收入3.09亿元,同比增长3.62%。归属于四川睿健医疗股东的净利润7890.5万元,同比增长8.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191112749","title":"普华和顺(01358)子公司四川睿健医疗披露2026年中期业绩:净利润7,673.51万元,同比增长9.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191112749","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191112749?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:31","pubTimestamp":1787308289,"startTime":"0","endTime":"0","summary":"2026年8月21日,普华和顺集团公司公告称,其非全资附属公司四川睿健医疗科技股份有限公司已在全国中小企业股份转让系统披露截至2026年6月30日止六个月的未审核运营数据。报告期内,四川睿健医疗实现收入3.09亿元,同比增加3.62%;实现税前利润9,302.21万元,同比增长8.89%。所得税费用为1,628.70万元,较上年同期的1,512.35万元增长7.69%;实现净利润7,673.51万元,同比增长9.15%。其中,归属于四川睿健医疗股东的净利润为7,890.50万元,较上年同期的7,292.36万元增加8.20%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170550865","title":"普华和顺(01358)将于2026年8月28日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1170550865","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170550865?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:37","pubTimestamp":1787042243,"startTime":"0","endTime":"0","summary":"普华和顺集团公司(01358)8月18日公告称,董事会已排期于2026年8月28日(星期五)召开会议,议程包括:一、审批本公司及其附属公司截至2026年6月30日止六个月的未經審核綜合中期业绩公告;二、审议是否派发中期股息(如有)。\\n\\n公告显示,董事会目前由6名成员组成,包括执行董事兼董事会主席及首席执行官张月娥女士;非执行董事姜黎威先生、林君山先生;以及独立非执行董事王小刚先生、陈庚先生、王凤丽女士。\\n\\n公司将于董事会会议后公布相关业绩及股息决定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658381429","title":"普华和顺(01358.HK)发盈警,预期中期股东应占溢利1300万元至2000万元 同比减少80%至70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658381429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658381429?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:07","pubTimestamp":1786360020,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01358","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pwmedtech.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.038},{"period":"3month","weight":-0.1541},{"period":"6month","weight":-0.1075},{"period":"1year","weight":-0.3363},{"period":"ytd","weight":-0.2457}],"compareEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0035},{"period":"6month","weight":-0.0259},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0322}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"普华和顺集团公司是一家主要从事医疗器械的研发(R&D)及销售业务的投资控股公司。该公司通过三个分部开展业务。输液器业务分部主要从事输液器、静脉留置针产品、胰岛素针等的研发、制造及销售。血液净化业务分部主要从事血液透析及血液净化医疗器械的研发、制造及销售。再生医用生物材料业务分部主要从事动物源性组织再生医用生物材料及人体组织修复替代产品的研发及制造。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.030998},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.007141},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.014897},{"month":4,"riseRate":0.615385,"avgChangeRate":0.059534},{"month":5,"riseRate":0.692308,"avgChangeRate":0.040387},{"month":6,"riseRate":0.461538,"avgChangeRate":0.035491},{"month":7,"riseRate":0.615385,"avgChangeRate":0.041059},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.032519},{"month":9,"riseRate":0.769231,"avgChangeRate":0.03351},{"month":10,"riseRate":0.5,"avgChangeRate":0.01727},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.038729},{"month":12,"riseRate":0.307692,"avgChangeRate":0.202103}],"exchange":"SEHK","name":"普华和顺","nameEN":"PW MEDTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普华和顺,01358,普华和顺股票,普华和顺股票老虎,普华和顺股票老虎国际,普华和顺行情,普华和顺股票行情,普华和顺股价,普华和顺股市,普华和顺股票价格,普华和顺股票交易,普华和顺股票购买,普华和顺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}